Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001513162-19-000110
Filing Date
2019-04-22
Accepted
2019-04-22 15:15:25
Documents
1
Period of Report
2019-04-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2963
  Complete submission text file 0001513162-19-000110.txt   4481
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Issuer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 8071 Services-Medical Laboratories

Mailing Address 6 AUTUMN LANE SARATOGA SPRINGS NY 12866
Business Address
Titterton Lewis H jr (Reporting) CIK: 0001499254 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37492 | Film No.: 19759316